Predictive value of GATA3 and Ki-67 expression in biopsy and transurethral resection specimens in patients with urothelial carcinoma of the urinary bladder

被引:1
作者
Sunjevic, Milena [1 ,2 ]
Bogdanovic, Jovo [3 ,4 ]
Trivunic-Dajko, Sandra [1 ,2 ]
机构
[1] Univ Novi Sad, Dept Pathol, Fac Med, Novi Sad, Serbia
[2] Univ Clin Ctr Vojvodina, Ctr Pathol & Histol, Novi Sad, Serbia
[3] Univ Novi Sad, Dept Surg, Fac Med, Novi Sad, Serbia
[4] Univ Clin Ctr Vojvodina, Urol Clin, Novi Sad, Serbia
关键词
urothelial carcinoma; biopsy; transurethral resection; GATA3; Ki-67; CANCER; UTILITY; P53;
D O I
10.2298/SARH220312072S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction/Objective Urothelial carcinoma is the most commonly diagnosed malignancy of urinary bladder in clinical and pathohistological practice where various prognostic factors play a significant role. One of the most important pathohistological prognostic factors is the intensity of immunohistochemical staining. Among various immunohistochemical markers that have been proven to influence disease progression and the patient's survival, role of Ki-67 and GATA3 in prediction of disease prognosis has not been completely clarified yet. The aim of this study was to determine the predictive value of GATA3 and Ki-67 mutual expression in urothelial carcinoma. Methods Eighty patients were included in this study, out of which four groups were formed based on the pathological stage of urothelial carcinoma. After using preferred antibodies, their staining intensity was analyzed semiquantitatively. Results Results showed that there was statistically significant correlation between the type of urothelial carcinoma, the pathological stage, and invasiveness and different grades of GATA3 expression, as well as statistically significant correlation between the type of urothelial carcinoma and the pathological stage and different grades of Ki-67 expression. The regression model showed low value of GATA3 and Ki-67 mutual expression. There was also statistical significance regarding the pathological stage and invasiveness of the tumor in survival analysis. Conclusion Predictive value of GATA3 and Ki-67 mutual expression resulted as low from this study, but to our knowledge this was the first study to examine their predictive capability on biopsy and transurethral resection specimens.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 26 条
  • [11] Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder
    Kamel, Nahla Abdelfattah
    Abdelzaher, Eman
    Elgebaly, Omar
    Ibrahim, Shery Abdullah
    [J]. JOURNAL OF HISTOTECHNOLOGY, 2020, 43 (01) : 21 - 28
  • [12] Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis
    Ko, Kyungtae
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    [J]. ONCOTARGET, 2017, 8 (59) : 100614 - 100630
  • [13] Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas
    Kvikstad, Vebjorn
    Mangrud, Ok Malfrid
    Gudlaugsson, Einar
    Dalen, Ingvild
    Espeland, Hans
    Baak, Jan P. A.
    Janssen, Emiel A. M.
    [J]. DIAGNOSTIC PATHOLOGY, 2019, 14 (01)
  • [14] Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion
    Leivo, Mariah Z.
    Sahoo, Debashis
    Hamilton, Zachary
    Mirsadraei, Leili
    Shabaik, Ahmed
    Parsons, John K.
    Kader, Andrew K.
    Derweesh, Ithaar
    Kane, Christopher
    Hansel, Donna E.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (01) : E1 - E10
  • [15] A risk-stratified approach to the management of high-grade T1 bladder cancer
    Mannas, Miles P.
    Lee, Taeweon
    Nykopp, Timo K.
    da Costa, Jose Batista
    Black, Peter C.
    [J]. CURRENT OPINION IN UROLOGY, 2018, 28 (06) : 563 - 569
  • [16] The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042
    Poirier, Abbey E.
    Ruan, Yibing
    Walter, Stephen D.
    Franco, Eduardo L.
    Villeneuve, Paul J.
    King, Will D.
    Volesky, Karena D.
    O'Sullivan, Dylan E.
    Friedenreich, Christine M.
    Brenner, Darren R.
    De, Prithwish
    Nuttall, Robert
    Smtih, Leah
    Demers, Paul
    Hystad, Perry
    El-Masri, Zeinab
    El-Zein, Mariam
    Narain, Tasha
    Gogna, Priyanka
    Holmes, Elizabeth
    [J]. CANCER EPIDEMIOLOGY, 2019, 59 : 199 - 207
  • [17] Sex Differences in Urothelial Bladder Cancer Survival
    Radkiewicz, Cecilia
    Edgren, Gustaf
    Johansson, Anna Louise Viktoria
    Jahnson, Staffan
    Haggstrom, Christel
    Akre, Olof
    Lambe, Mats
    Dickman, Paul William
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (01) : 26 - +
  • [18] The global burden of urinary bladder cancer: an update
    Richters, Anke
    Aben, Katja K. H.
    Kiemeney, Lambertus A. L. M.
    [J]. WORLD JOURNAL OF UROLOGY, 2020, 38 (08) : 1895 - 1904
  • [19] SIEGEL RL, 2021, CA-CANCER J CLIN, V71, P7, DOI [DOI 10.3322/caac.21387, DOI 10.3322/CAAC.21654]
  • [20] Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer
    Sjostrom, Carin
    Thorstenson, Andreas
    Strock, Viveka
    Hosseini-Aliabad, Abolfazl
    Aljabery, Firas
    Liedberg, Fredrik
    Sherif, Amir
    Malmstrom, Per-Uno
    Rosell, Johan
    Gardmark, Truls
    Jahnson, Staffan
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (03) : 186 - 193